NCT02834442View on ClinicalTrials.gov

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of MT-7117 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Healthy
Interventions
DRUG

MT-7117

DRUG

Placebo

Trial Locations (1)

Unknown

Investigational center, United Kingdom

Sponsors
All Listed Sponsors
lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY